Literature DB >> 31562561

[Surgical resection with ophthalmoplastic reconstruction : Gold standard in periocular basal cell carcinoma].

A C Rokohl1, A Kopecky2,3, Y Guo4, V Kakkassery5, J M Mor4, N Loreck4, K R Koch4, L M Heindl4,6.   

Abstract

The gold standard for the treatment of periocular basal cell carcinoma is surgical resection followed by ophthalmoplastic reconstruction. The highest priority in most cases is the complete histopathologically controlled tumor excision. The histopathological preparation can be carried out in two stages by rapid overnight embedding or intraoperatively by a rapid frozen section procedure. A variety of reconstruction methods enable a customized and in most cases also a cosmetically and functionally attractive defect coverage. Postoperatively, a regularly performed tumor aftercare is essential.

Entities:  

Keywords:  Defect coverage; Frozen sections; Histopathology; Reconstruction methods; Tumor excision

Mesh：

Year:  2020        PMID： 31562561     DOI： 10.1007/s00347-019-00973-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  21 in total

1.  Myocutaneous flap (V-Y design) from the nasal bridge for medial canthal reconstruction.

Authors:  E A Moretti; F Gomez Garcia
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1998-07       Impact factor: 1.746

Review 2.  [Personalized medicine in the treatment of periocular tumors : Targeted treatment and use of immune checkpoint inhibitors].

Authors:  Alexander C Rokohl; Konrad R Koch; Joel M Mor; Niklas Loreck; Max Schlaak; Cornelia Mauch; Nikolaos E Bechrakis; Armin Mohi; Vinodh Kakkassery; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-06       Impact factor: 1.059

3.  Trans-nasal flap for medial canthal reconstruction.

Authors:  P L Custer
Journal:  Ophthalmic Surg       Date:  1994 Sep-Oct

4.  [Young male patient with unusual space-occupying lesion of the lower eyelid].

Authors:  Alexander C Rokohl; Heike Löser; Joel M Mor; Niklas Loreck; Konrad R Koch; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-01       Impact factor: 1.059

5.  [Predictors of recurrent basalioma of the eyelids and periorbital region].

Authors:  A C Zimmermann; V Klauss
Journal:  Ophthalmologe       Date:  2001-06       Impact factor: 1.059

Review 6.  [Current diagnostics and therapy recommendations for ocular basal cell carcinoma].

Authors:  V Kakkassery; K U Loeffler; M Sand; K R Koch; A M Lentzsch; A C Nick; I A Adamietz; L M Heindl
Journal:  Ophthalmologe       Date:  2017-03       Impact factor: 1.059

7.  The switch flap in eyelid reconstruction.

Authors:  S N Stafanous
Journal:  Orbit       Date:  2007-12

8.  [Advanced periocular basal cell carcinoma-a therapeutic challenge].

Authors:  B Lauterbach; V Kakkassery; D Debus; L M Heindl; E S Schultz
Journal:  Ophthalmologe       Date:  2019-03       Impact factor: 1.059

9.  [SOP - Standarized procedures in diagnostics and therapies of periocular basal cell carcinoma].

Authors:  Vinodh Kakkassery; Ludwig M Heindl
Journal:  Klin Monbl Augenheilkd       Date:  2017-10-09       Impact factor: 0.700

Review 10.  [Rehabilitation of Anophthalmic Patients with Prosthetic Eyes in Germany Today - Supply Possibilities, Daily Use, Complications and Psychological Aspects].

Authors:  Alexander C Rokohl; Joel M Mor; Marc Trester; Konrad R Koch; Ludwig M Heindl
Journal:  Klin Monbl Augenheilkd       Date:  2018-12-19       Impact factor: 0.700
View more
  1 in total

1.  Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib.

Authors:  Alexander C Rokohl; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-02       Impact factor: 3.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.